1.
Katja Sockel, Martin Wermke, Jörgen Radke, Alexander Kiani, Markus Schaich, Martin Bornhäuser, Gerhard Ehninger, Christian Thiede, Uwe Platzbecker. Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse. Haematologica 2011;96(10):1568-1570; https://doi.org/10.3324/haematol.2011.044388.